Lung Cancer Stage I
12
3
5
1
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 75/100
8.3%
1 terminated out of 12 trials
50.0%
-36.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (12)
Avecure Flexible Microwave Ablation Probe For Lung Nodules
Outside the Cage (OTC) Robotic Lobectomy
A Registry for People With Lung Cancer
Intra-operative Air Leak Management After Minimally Invasive Lung Segmental Resection
Feasibility Study to Treat Lung Cancer With the Permanently Implantable LDR CivaSheet®
SCION: SABR and Checkpoint Inhibition of NSCLC
Calypso Guided High Precision Stereotactic Ablative Radiosurgery for Lung TUmours Using Real-Time Tumour Tracking & Respiratory Gating
Postoperative Chronic Operation-related Symptoms After Minimally Invasive Lung Surgery
Enabling Remote Access to Breathe Easier: A Novel Approach to Improve Symptom Management
Cardiac Changes After Stereotactic Radiotherapy for Early Stage NSCLC Cancer or Lung Metastasis
Progressive Web App About Individualized Patient Decision Aid for NSCLC Stage I-II
Clinical Evaluation of Vagal Nerve Preservation in Minimally Invasive Surgery for Early Lung Cancer